Media

Orexo continues to strengthen IP rights for ZUBSOLV®

Aprea Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Update on Business Operations

Orexo publishes prospectus and applies for admission to trading of corporate bonds

Oncopeptides announces that the first patients in the United States are being treated with PEPAXTO®

Vicore Pharma’s drug candidate C21 dilates peripheral resistance vessels in fibrotic disease

Oncopeptides has completed a directed share issue raising approximately SEK 1,106 million (USD 130 million)

Oncopeptides strengthens leadership in Europe and opens an Early Access Program in multiple myeloma

Press release from the extraordinary general meeting of Vicore Pharma Holding AB (publ)

Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update